NCT03816020View on ClinicalTrials.gov

NAD-supplementation in Drug naïve Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 9, 2019

Primary Completion Date

February 10, 2020

Study Completion Date

February 10, 2020

Conditions
Parkinson DiseaseNeurodegenerative Diseases
Interventions
DIETARY_SUPPLEMENT

Nicotinamide Riboside

Nicotinamide Riboside capsules 250mg x 2 BID

OTHER

Placebo

Placebo capsules BID

Trial Locations (1)

5021

Haukeland University Hospital, Bergen

All Listed Sponsors
lead

Haukeland University Hospital

OTHER

NCT03816020 - NAD-supplementation in Drug naïve Parkinson's Disease | Biotech Hunter | Biotech Hunter